British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects / Q000379:methods / Q000592:standards; D004334:Drug Administration Schedule; D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods; D024882:Drug Resistance, Viral; D019317:Evidence-Based Medicine; D018149:Glucose Intolerance / Q000139:chemically induced / Q000517:prevention & control; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced / Q000517:prevention & control; D018579:Patient Selection; D012107:Research Design / Q000592:standards; D016879:Salvage Therapy / Q000379:methods; D013997:Time Factors; D016896:Treatment Outcome
D019380:Anti-HIV Agents